miRNA在腹主动脉瘤中的研究进展
作者:
作者单位:

(1. 中国医学科学院北京协和医院血管外科,北京 100730;2. 中国医学科学院/北京协和医学院药用植物研究所生物信息中心,北京 100193)

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金重大项目(51890894);国家自然科学基金面上项目(81770481,82070492)


Research progress of miRNA in abdominal aortic aneurysm
Author:
Affiliation:

(1. Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China;2. Department of Computational Biology and Bioinformatics, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    主动脉瘤是威胁人类健康的重要疾病,一般表现为主动脉病理性的扩张,以腹主动脉瘤最为常见。miRNA是一类单链非编码小RNA,广泛参与转录后基因表达的调控。随着近年研究的逐渐深入,miRNA已被视作腹主动脉瘤进展中的重要调控分子。理解miRNA在腹主动脉瘤发生发展中的调控机制,有助于疾病的早期诊断、靶向治疗及预后判断。

    Abstract:

    Aortic aneurysm(AA) is an important disease threatening human health. The general performance of AA is the pathological dilation of the aorta, and abdominal aortic aneurysm(AAA) is the most common type. miRNA is known as the single-stranded non-coding small RNA, which is widely involved in the regulation of post-transcriptional gene expression. With the deepening of research, miRNA has been regarded as a crucial regulatory molecule in the development of AAA. Understanding the regulatory role that miRNA plays in the development of AAA contributes to the early diagnosis and targeted therapy of AAA and facilitates the prognosis estimation.

    参考文献
    相似文献
    引证文献
引用本文

吴亮霖,杨丹,郑月宏. miRNA在腹主动脉瘤中的研究进展[J].中华老年多器官疾病杂志,2021,20(12):924~927

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-06-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-01-10
  • 出版日期: